feedback
facebook page
Follow Me on Pinterest
twitter page
google plus page
rss feed

Home > Recalled Products > Drugs > Elevated Impurity

When reviewing recalls, be sure to check all potentially matching product types. To register belongings for recall information and alerts,
use Items I Own. To check and monitor retail or resale inventory for recalls, use Simply Check.

Narrow Recalls by:


Lead
Elevated Impurity

Drugs Recalled Due to Elevated Impurity

Since May 01, 2013

GSMS Inc. Losartan Potassium Tablets

A recall was published by the FDA on 2019-06-10 due to a potential elevated impurity hazard.


GSMS Incorporated Losartan Potassium 25 Mg And 100 Mg Tablets USP

A recall was published by the FDA on 2019-04-26 due to a potential elevated impurity hazard.


Legacy Losartan Potassium USP

A recall was published by the FDA on 2019-04-24 due to a potential elevated impurity hazard.


Legacy Losartan Potassium Tablets, USP, 25mg, 50mg, And 100mg

A recall was published by the FDA on 2019-03-25 due to a potential elevated impurity hazard.


Legacy Losartan Potassium Tablets, USP, 50mg

A recall was published by the FDA on 2019-03-15 due to a potential elevated impurity hazard.


Stokes Healthcare Pilocarpine Opthalmic Solution

A recall was published by the FDA on 2019-03-13 due to a potential elevated impurity hazard.


Aurobindo Valsartan Tablets, USP, 160 Mg

A recall was published by the FDA on 2019-03-07 due to a potential elevated impurity hazard.


Torrent Losartan Potassium Tablets USP And Losartan Potassium/hydrochlorothiazide Tablets USP

A recall was published by the FDA on 2019-03-01 due to a potential elevated impurity hazard.



<< Prev | 1 | 2 | 3 | Next >>